EverydayHealthLogo
MR

Dr. Marlene Rabinovitch, MD

Palo Alto, CA

52 Years of Experience

Accepting patients

    Who is Dr. Rabinovitch, Pediatric Cardiologist in Palo Alto, CA?

    Dr. Marlene Rabinovitch, MD is a Pediatric Cardiologist, who primarily practices in Palo Alto, CA. She has been practicing for over 52 years and is board certified by the American Board of Pediatrics. Dr. Rabinovitch graduated from McGill University Faculty of Medicine and completed her residency at University of Colorado Program A. Dr. Rabinovitch is fluent in English and French, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Rabinovitch’s office at (650) 497-8000.

    Where did Dr. Rabinovitch go to medical school and complete their residency?

    • Residency: University of Colorado Program A

    • Medical School: McGill University Faculty of Medicine

    Is Dr. Rabinovitch board certified in Pediatric Cardiologist?

    Yes, Dr. Marlene Rabinovitch, MD is board certified by the American Board of Pediatrics

    What languages does Dr. Rabinovitch speak?

    Dr. Rabinovitch and their clinical team can communicate with patients in the following languages:

    • English

    • French

    Which conditions does Dr. Rabinovitch treat as a Pediatric Cardiologist?

    As a Pediatric Cardiologist, conditions treated by a Dr. Marlene Rabinovitch may include:

    Please contact Dr. Rabinovitch's office for more information or to schedule a consultation.

    Which procedures does Dr. Rabinovitch perform as a Pediatric Cardiologist?

    As a Pediatric Cardiologist, procedures performed by a Dr. Marlene Rabinovitch may include:

    For detailed information, please contact Dr. Rabinovitch's office.

    Does Dr. Rabinovitch accept my insurance?

    Please contact Dr. Rabinovitch's office to confirm accepted insurance plans.

    Where is Dr. Rabinovitch's office located?

    Dr. Marlene Rabinovitch's Primary Practice

    725 Welch Rd

    Palo Alto, CA 94304

    (650) 497-8000

    Get Directions

    Recognitions

    Publications

    Reduced BMPR2 expression induces GM

    jourl of experimental medicine, 2014

    FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmory hypertension.

    jourl of clinical investigation, 2013

    Combining induced pluripotent stem cell with next generation sequencing technology to gain new

    Pulmory circulation, 2013

    Loss of adenomatous poliposis coli

    Circulation research, 2012

    Neutrophil Elastase Is Produced by Pulmory Artery Smooth Muscle Cells

    AMERICAN JOURL OF PATHOLOGY, 2011

    Disruption of PPAR gamma

    JOURL OF CLINICAL INVESTIGATION, 2011

    Inhibition of Transforming Growth Factor beta Worsens Elastin Degradation

    AMERICAN JOURL OF PATHOLOGY, 2011

    BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt

    JOURL OF CELL BIOLOGY, 2011

    Tie2-mediated loss of peroxisome proliferator

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2009

    S100A4 and Bone Morphogenetic Protein

    CIRCULATION RESEARCH, 2009

    Bone morphogenetic protein 2 induces pulmory angiogenesis via Wnt-beta-catenin

    JOURL OF CELL BIOLOGY, 2009

    SM22 alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac

    DEVELOPMENT, 2008

    An antiproliferative BMP

    JOURL OF CLINICAL INVESTIGATION, 2008

    Relevant issues in the pathology and pathobiology of pulmory hypertension.

    Jourl of the American College of Cardiology, 2013

    Chronic effects of pulmory artery stenosis on hemodymic and structural development of the lungs

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2013

    Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmory Hypertension

    CIRCULATION RESEARCH, 2011

    Inhibiting Lung Elastase Activity Ebles Lung Growth in Mechanically Ventilated Newborn Mice

    AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011

    PPAR gamma and the Pathobiology of Pulmory Arterial Hypertension

    Rabinovitch, M., 2010

    Prolonged mechanical ventilation with air induces apoptosis

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2010

    Cholinergic Modulation of Angiogenesis: Role of the 7 Nicotinic Acetylcholine Receptor

    JOURL OF CELLULAR BIOCHEMISTRY, 2009

    LC3-mediated fibronectin mR translation induces fibrosarcoma growth by increasing connective tissue

    JOURL OF CELL SCIENCE, 2009

    Balloon occlusion pulmory wedge angiography

    CARDIOLOGY IN THE YOUNG, 2009

    Insulin resistance in pulmory arterial hypertension

    EUROPEAN RESPIRATORY JOURL, 2009

    VEGF blockade inhibits angiogenesis and reepithelialization of endometrium

    FASEB JOURL, 2008

    Molecular pathogenesis of pulmory arterial hypertension

    JOURL OF CLINICAL INVESTIGATION, 2008

    Pulmory arterial remodeling induced by a Th2 immune response

    JOURL OF EXPERIMENTAL MEDICINE, 2008

    Smooth muscle protein 22 alpha

    CIRCULATION RESEARCH, 2008

    Reactivation of gamma HV68 induces neointimal lesions in pulmory arteries of S100A4

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008

    Developmental expression of LC3 alpha and beta

    DEVELOPMENTAL DYMICS, 2008

    Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008

    Mechanical ventilation with 40% oxygen reduces pulmory expression of genes that regulate lung

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007

    Point: Counterpoint: Chronic hypoxia-induced pulmory hypertension does

    JOURL OF APPLIED PHYSIOLOGY, 2007

    Dysregulation of pulmory elastin synthesis and assembly in preterm lambs with chronic lung disease

    AMERICAN JOURL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007

    Nuclear factor-kappa B activation in neotal mouse lung protects against lipopolysaccharide

    AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007

    Pulmory arterial hypertension is linked to insulin resistance

    CIRCULATION, 2007

    Pathobiology of pulmory hypertension

    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2007

    Cellular and molecular pathobiology of pulmory hypertension conference summary

    CHEST, 2005

    Mts1/S100A4 stimulates human pulmory artery

    CHEST, 2005

    Caspases from apoptotic myocytes degrade extracellular matrix: a novel remodeling paradigm.

    FASEB jourl, 2005

    Gene transfer of prostaglandin synthase maintains patency of the newborn lamb arterial duct

    PEDIATRIC RESEARCH, 2005

    Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmory hypertension

    CIRCULATION RESEARCH, 2005

    Interdependent serotonin transporter and receptor pathways regulate S100A4

    CIRCULATION RESEARCH, 2005

    Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis

    CIRCULATION, 2005

    Subversion of cellular autophagosomal machinery by R viruses

    PLOS BIOLOGY, 2005

    Apolipoprotein D and platelet-derived growth factor

    CIRCULATION RESEARCH, 2004

    Elafin-overexpressing mice have improved cardiac function after myocardial infarction

    AMERICAN JOURL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004

    Pulmory arterial hypertension - Future directions - Report of a tiol Heart

    CIRCULATION, 2004

    Cellular and molecular pathobiology of pulmory arterial hypertension

    JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004

    The mouse through the looking glass - A new door into the pathophysiology of pulmory hypertension

    CIRCULATION RESEARCH, 2004

    S100A4/Mts1 produces murine pulmory

    AMERICAN JOURL OF PATHOLOGY, 2004

    S100A4/Mts1 produces murine pulmory

    Am J Pathol, 2004

    Apolipoprotein D and PDGF-BB synergism mediates vascular smooth muscle cell migration.

    Circ Res, 2004

    Apolipoprotein D inhibits platelet-derived growth factor

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003

    Low molecular weight heparin

    Circulation, 2003

    Temporal response and localization of integrins beta 1 and beta 3

    CIRCULATION, 2003

    Elafin overexpressing mice have improved cardiac function after myocardial infarction.

    Am J Physiol Heart Circ Physiol, 2003

    Apolipoprotein D inhibits PDGF induced v

    Arterioscler Thromb Vasc Biol, 2003

    Dexfenfluramine protects against pulmory hypertension in rats

    JOURL OF APPLIED PHYSIOLOGY, 2002

    Understanding and treating vein graft atherosclerosis

    CARDIOVASCULAR PATHOLOGY, 2002

    Pulmory arterial hypertension in congenital heart disease.

    Cardiology clinics, 2002

    Novel notions on newborn lung disease

    TURE MEDICINE, 2002

    Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis

    JOURL OF CLINICAL INVESTIGATION, 2002

    Fetal pulmory artery diameters and their association with lung hypoplasia and posttal outcome

    AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2002

    Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic

    CIRCULATION, 2002

    Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation

    JOURL OF CLINICAL INVESTIGATION, 2001

    Pathobiology of pulmory hypertension - Extracellular matrix

    CLINICS IN CHEST MEDICINE, 2001

    Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001

    Tumor necrosis factor

    CIRCULATION RESEARCH, 2001

    Conditiol and targeted overexpression of vascular chymase causes hypertension in transgenic mice

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2001

    A novel vascular smooth muscle chymase is upregulated in hypertensive rats

    JOURL OF CLINICAL INVESTIGATION, 2001

    Hemodymic unloading leads to regression of pulmory vascular disease in rats

    O'Blenes, S. B., Fischer, S., McIntyre, B., Keshavjee, S., RABINOVITCH, 2001

    Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration.

    Circulation, 2000

    Isolated ductus arteriosus aneurysm in the fetus and infant: A multi-institutiol experience

    JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000

    Complete reversal of fatal pulmory hypertension in rats by a serine elastase inhibitor

    TURE MEDICINE, 2000

    Suppressed smooth muscle proliferation

    JOURL OF CLINICAL INVESTIGATION, 2000

    Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP

    FASEB JOURL, 2000

    Under new magement - A six-month progress report on Circulation Research

    CIRCULATION RESEARCH, 2000

    Elastase and matrix metalloproteise inhibitors induce regression

    JOURL OF CLINICAL INVESTIGATION, 2000

    Pathobiology of pulmory hypertension: Impact on clinical magement.

    Semirs in thoracic and cardiovascular surgery. Pediatric cardiac surge, 2000

    Adventitial fibroblasts - Defining a role in vessel wall remodeling

    AMERICAN JOURL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000

    Circulation research Editors' yearly report: 1999-2000

    Circulation research, 2000

    Pulmory hypertension: Pathophysiology as a basis for clinical decision making

    JOURL OF HEART AND LUNG TRANSPLANTATION, 1999

    Functiol and antigenic concentrations of alpha-1

    Stiskal, J. A., Ito, S., Cox, D. W., Shenn, A. T., O'Brien, K. K., Kel, 1999

    Nitric oxide mediates LC-3

    FASEB JOURL, 1999

    EVE and beyond, retro and prospective insights

    Rabinovitch, M., 1999

    Survival of Mycobacterium avium

    INFECTION AND IMMUNITY, 1999

    Regression of hypertrophied rat pulmory arteries

    CIRCULATION RESEARCH, 1999

    Targeted overexpression of elafin protects mice against cardiac dysfunction

    JOURL OF CLINICAL INVESTIGATION, 1999

    Induction of vascular smooth muscle cell tescin

    JOURL OF CELL SCIENCE, 1999

    Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting

    TURE MEDICINE, 1999

    A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function

    TURE MEDICINE, 1998

    Tissue-specific and developmental regulation of transforming growth factor-beta

    PEDIATRIC RESEARCH, 1998

    Microtubule involvement in translatiol regulation of fibronectin expression by light chain 3 of

    CIRCULATION RESEARCH, 1998

    Elastase and the pathobiology of unexplained pulmory hypertension

    CHEST, 1998

    AML1-like transcription factor induces serine elastase activity in ovine pulmory artery smooth

    CIRCULATION RESEARCH, 1998

    Mechanisms of proliferative and obliterative vascular diseases

    AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998

    Endothelial and serum factors which include apolipoprotein A1 tether elastin to smooth muscle cells

    JOURL OF CELLULAR PHYSIOLOGY, 1998

    Microtubule-associated protein 1 light chain 3 is a fibronectin mR

    JOURL OF CLINICAL INVESTIGATION, 1997

    Regulation of tescin-C

    JOURL OF CELL BIOLOGY, 1997

    New insights and therapeutic strategies for postcardiac transplantation corory artery disease

    RABINOVITCH, M., 1997

    Pulmory hypertension: Updating a mysterious disease

    CARDIOVASCULAR RESEARCH, 1997

    Tescin-C, proliferation and subendothelial fibronectin in progressive pulmory vascular disease

    AMERICAN JOURL OF PATHOLOGY, 1997

    The committed vascular smooth muscle cell: A question of 'timing' or 'response to pressure' or both

    AMERICAN JOURL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997

    Carbon monoxide formation in the ductus arteriosus in the lamb

    BRITISH JOURL OF PHARMACOLOGY, 1997

    Cell-extracellular matrix interactions in the ductus arteriosus and perital pulmory circulation

    SEMIRS IN PERITOLOGY, 1996

    Tescin-C is induced with progressive pulmory vascular disease in rats

    CIRCULATION RESEARCH, 1996

    Gerbode's defect associated with acute sinus node dysfunction as a complication of infective

    HEART, 1996

    It all begins with eve (endogenous vascular elastase)

    RABINOVITCH, M., 1996

    Fusion of Leishmania amazonensis par

    BRAZILIAN JOURL OF MEDICAL AND BIOLOGICAL RESEARCH, 1996

    Elafin, a serine elastase inhibitor

    JOURL OF CLINICAL INVESTIGATION, 1996

    Functiol interplay between interleukin-1 receptor

    EXPERIMENTAL CELL RESEARCH, 1996

    Cohabitation of Leishmania amazonensis and Coxiella burnetii

    TRENDS IN MICROBIOLOGY, 1996

    Exogenous leukocyte

    JOURL OF CELLULAR PHYSIOLOGY, 1996

    Elastase and cell matrix interactions in the pathobiology of vascular disease.

    Acta paediatrica Japonica; Overseas edition, 1995

    INCREASED ELASTIN-DEGRADING ACTIVITY AND NEOINTIMAL FORMATION IN PORCINE AORTIC ORGAN

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995

    Cytokine-mediated fibronectin production

    RABINOVITCH, M., Molossi, S., Clausell, N., 1995

    EXPERIENCE WITH REPAIR OF CONGENITAL HEART-DEFECTS USING ADJUNCTIVE ENDOVASCULAR DEVICES

    Coles, J. G., Yemets, I., jm, H. K., Lukanich, J. M., Perron, J., Wils, 1995

    INCREASED RESPIRATORY SYSTEM RESISTANCE AND BRONCHIAL SMOOTH

    AMERICAN JOURL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995

    LYMPHOCYTE TRANSENDOTHELIAL MIGRATION TOWARD SMOOTH-MUSCLE CELLS IN INTERLEUKIN

    JOURL OF CELLULAR PHYSIOLOGY, 1995

    ABNORMALITIES IN INTRAMYOCARDIAL ARTERIES DETECTED IN CARDIAC TRANSPLANT BIOPSY SPECIMENS

    JOURL OF THE

    What is Dr. Rabinovitch's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Rabinovitch's National Provider Identifier (NPI) number is 1861414906.

    What common questions do patients ask about Dr. Rabinovitch?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Rabinovitch

    What is Dr. Marlene Rabinovitch's specialty?

    Dr. Rabinovitch is a Pediatric Cardiologist near Palo Alto, CA. A pediatric cardiologist provides comprehensive care for children with cardiovascular issues, offering expertise in diagnosing, treating, and managing heart and blood vessel conditions. This specialist is skilled in selecting, performing, and interpreting structural and functional assessments of the heart and blood vessels, as well as conducting thorough clinical evaluations of cardiovascular diseases in young patients. Contact Dr. Rabinovitch to book an appointment today.

    Is this Dr. Marlene Rabinovitch affiliated with a ranked Castle Connolly Top Hospital?

    No, Rabinovitch is not affiliated with a Castle Connolly Top Hospital, but is affiliated with the following hospitals: Stanford Medicine Children’s Health. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Pediatric Cardiologist?

    Explore Pediatric Cardiologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Marlene Rabinovitch accepting new patients in Palo Alto, CA?

    Yes, Dr. Marlene Rabinovitch is accepting new patients at this time.

    Does Dr. Marlene Rabinovitch offer online booking?

    Please contact Dr. Rabinovitch's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Marlene Rabinovitch?

    Please contact Dr. Rabinovitch's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Marlene Rabinovitch have?

    Dr. Marlene Rabinovitch is certified by the American Board of Pediatrics.

    Other Pediatric Cardiologist Near Palo Alto, CA

    BF

    Pediatric Cardiologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    EE

    Pediatric Critical Care Medicine Specialist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    DS

    Pediatric Cardiologist

    acceptingPatients-iconAccepting patients
    Palo Alto, CA
    See All Specialists

    Doctors by Category

    Specialists